H5N1 Bird Flu Threat: Experts Sound Alarm Over Potential Pandemic As Infections Spread To All 50 US States
There is a possibility for virus adaptation and widespread infections among humans, they warned
The latest data also revealed that there are "ongoing mutations" across the circulating avian influenza viruses
The warning comes as the HHS pursues an overhaul of the US public health system
Virology experts from across 40 countries have sounded the alarm over the rising threat of H5N1 avian flu, a subtype of the influenza A virus that causes respiratory disease in birds (avian influenza or bird flu), and has now affected humans too.
In a commentary published this week in the medical journal The Lancet Regional Health – Americas, top virologists warned of the recent emergence of "highly pathogenic" H5N1 infections not only in dairy cows, but also in humans in the U.S.
Dozens of individuals affected: Virologists
According to the virologists, there have been over 995 dairy cows and at least 70 humans affected by the virus infections, including a severe case that became the "first reported H5N1-related death in the U.S."
The infections were recorded from 2024 through April 2025, "with the epizootic now present in all 50 states and human cases in 13 states and Canada."
They also cited a February report by the Centers for Disease Control and Prevention (CDC) that highlighted increased evidence of the virus's transmission to people.
"While the H5N1 outbreak in dairy cows and associated farm workers has not resulted in sustained human-to-human transmission, the possibility of virus adaptation and widespread infections requires proactive and vigilant measures," they pointed out.
They also urged leaders not just in the United States, but across the world, to improve preventive measures by utilizing all the knowledge painfully learned during the COVID-19 pandemic.
Evidence shows the virus is mutating
Aside from a growing number of people getting infected with the virus, sequencing data from circulating avian influenza viruses suggest "ongoing mutations and reassortment/mixing of genomic segments."
The widespread viral circulation has apparently affected not only dairy cows, but also other mammal species, including suspected cases in sea lions and minks.
"In mammals, these viruses may acquire mutations that increase their ability to transmit and replicate efficiently in mammals, eventually including humans," they warned, though they noted that such cases have yet to be demonstrated.
How worried should Americans be?
The virologists explained that in the past human H5N1 infections were primarily from bird-to-human transmission. However, recent data indicated that the situation had changed.
Furthermore, the proportion of undiagnosed human infections is currently unknown, which further raises the risk of exposure and eventual infection.
According to the experts, the following can play a role in the transmission of H5N1 to humans: Contaminated poultry products
Improper pasteurization and improper cooking of poultry and dairy products
Handling of infected poultry or cows
Direct contact with products from infected cows or poultry
Domestic pets that consume infected birds
The experts have urged leaders to improve various measures to prevent the bird flu's spread, including for biosecurity and biocontainment in farms, as well as awareness campaigns to keep the public informed about the avian influenza.
Warning comes at critical time in federal government
The virology warning comes at a time when concerns are rife over the Department of Health and Human Services (HHS), which recently saw staff reductions across a wide range of professionals, including researchers and medical experts.
The layoffs reportedly included some staff members of the U.S. Food and Drug Administration (FDA) who worked on the agency's response to the bird flu.
Despite the potential for a bird flu pandemic, Health Secretary Robert F. Kennedy Jr. seems committed to his initiative of overhauling the public health system and dismantling institutions he deems are not critical.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
4 days ago
- Int'l Business Times
At No Cost to Federal Government a Lifeline for America's Communities
As the U.S. healthcare system wrestles with rising costs and deepening disparities, one federal program quietly continues to serve as a financial and clinical lifeline for millions of Americans: the 340B Drug Pricing Program. Since its inception in 1992, 340B has enabled safety net hospitals, community health centers, and other providers to purchase outpatient medications at reduced prices. These savings aren't about boosting bottom lines—they're about keeping doors open, expanding access to care, and delivering essential services for all. At its heart, 340B is about getting medicine—and the healthcare services needed to ensure their safe and effective use—to people who otherwise might go without it. It empowers hospitals that serve high numbers of uninsured and modest-income patients, as well as Federally Qualified Health Centers (FQHCs) and Ryan White clinics that reach the working poor. The savings realized under 340B are not pocketed. These providers invest funds directly into programs that offer mental health services, treat substance use disorders, fund mobile clinics, and support chronic disease management. In many cases, access to the 340B program is the determining factor in whether a provider can afford to keep its pharmacy open to serve those who would otherwise go without treatment. The 340B program is a small program with big benefits. The discounts provided account for only 3% of drug companies' global revenues . At the same time, drug price increases continue to rise faster than inflation. In the United States, where drug companies already benefit from federally supported insurance programs and drug prices that are over three times higher than the rest of OECD countries, the 340B program is a reasonable accommodation to meet their obligations to be good corporate citizens. While the impact of the 340B program on drug companies is minimal, the impact on health is significant. Take community health centers, for example. These organizations are often the only providers in rural towns or urban neighborhoods. With the help of 340B, they can offer sliding scale fees, reach out to patients who are unhoused or living in poverty, and provide preventive care and health screenings that are crucial in addressing rising healthcare costs. For diseases like diabetes, 340B drug pricing ensures access to both medications as well as the patient education and healthcare provider services needed to effectively manage a complex chronic condition. In short, they make health more than a buzzword—they make it real. Hospitals also depend on 340B to sustain emergency rooms, neonatal intensive care units, and oncology programs. Small rural hospitals in particular often rely on these savings to remain operational. When one of these facilities shuts down, the consequences are immediate and severe: longer travel times for urgent care, delayed treatments, and a deeper strain on already stressed healthcare systems. Despite its impact, 340B has come under fire from some in the pharmaceutical industry and others who argue the program is being misused or lacks sufficient oversight. While oversight improvements are a worthy discussion, such criticisms ignore the real-world pressures providers face: skyrocketing drug prices, declining reimbursements, and the increasing demand for services as the population ages and grows more medically complex. Along with reasonable reforms that support program integrity, it's time to make common sense changes to reduce the regulatory burden on providers and let them focus on their main job—delivering high-quality health care to all. In the current budgetary environment, maintaining the 340B program is more important than ever. The program doesn't add to the federal budget. Instead, it gives healthcare providers the means to stretch existing resources further—just as Congress intended. Reducing or eliminating the 340B program to increase the profit of global pharmaceutical companies would shift costs to patients while simultaneously putting additional strains on state and federal budgets at the worst possible time. Undermining the 340B program would not just threaten individual institutions—it would unravel an already fragile health infrastructure. The people most affected would be those with the fewest options: modest and low-wage workers, rural residents, and those without insurance. The 340B program is a critical bridge between affordability and access, between policy and people. While reforms of the program may be useful, it is imperative they be guided with an overarching goal of improving how the program works for patients, not of providing a windfall for pharmaceutical manufacturers, who have experienced record profits since the program's inception. Weakening the 340B program would be short-sighted and harmful. Strengthening it is a fiscal imperative—for hospitals, clinics, and all communities. Author: Jane L. Delgado, Ph.D., M.S., is a highly esteemed and in-demand analyst and thought leader. She is the President and CEO of an NGO, Healthy Americas Foundation (HAF). She sits on the boards of the U.S. Soccer Foundation (Chair, Audit), McLean Hospital (Belmont, MA), the National Biodefense Science Advisory Board, the Lovelace Biomedical Research Institute (Investment Committee), and Argonne National Labs (Chair, Compensation).
Int'l Business Times
5 days ago
- Int'l Business Times
Poor Families Face Freezing Risks As Trump Admin's Budget Eliminates 'Vital' Program Keeping Them Warm in the Winter
The Trump administration's 2026 budget request cuts funding for an essential assistance program which helps poor families stay warm during the winter months. The administration's proposed cuts to the Department of Health and Human Services include cutting funding for the Low-Income Home Energy Assistance Program (LIHEAP), a federal block grant program which assists millions of low-income households with paying energy bills, reported the Huffington Post. Many of the households that depend on LIHEAP include children, disabled people and seniors. Over 6 million households are actively dependent on LIHEAP for household temperature regulation year round. "Savings come from eliminating radical diversity, equity and inclusion (DEI) and critical race theory programs, which weaponized large swaths of the Federal Government against the American people and moving programs that are better suited for States and localities to provide," reads the HHS budget brief, which then proceeds to state that LIHEAP funding should be decreased. The administration has already severely impaired the program by putting its entire staff on administrative leave from April 1 through June 2, after which it stated that they would be terminated along with thousands of other federal employees. However, in-progress lawsuits launched in May by a coalition of 20 state attorney generals declared this move unlawful, and asked for the reinstatement of these federal employees. Rep. Mike Lawler (R-NY) made a direct plea to HHS Secretary Robert F. Kennedy Jr., reiterating how "vital" LIHEAP is to his constituents. "The program supports our most vulnerable populations, including seniors, individuals with disabilities, and households with young children under the age of six," Lawler wrote in a letter to Kennedy. "In FY 2023, 24% of New Yorkers reported being unable to pay their energy bill at least once in a 12-month period. During FY 2023, LIHEAP also helped prevent over 100,000 utility disconnections in New York alone, highlighting this program's critical need." Furthermore, Republican Senators Susan Collins and Lisa Murkowski wrote a joint bipartisan letter in defense of LIHEAP. "We write regarding reports that you have terminated staff responsible for administering the Low-Income Home Energy Program," reads their letter, signed by 13 senators. "If true, these terminations threaten to devastate a critical program dedicated to helping Americans afford their home energy bills. "It is an indispensable lifeline, helping to ensure that recipients do not have to choose between paying their energy bills and affording other necessities like food and medicine," said the senators. Originally published on Latin Times
Int'l Business Times
5 days ago
- Int'l Business Times
GOP Senator Mocks Constituents' Concerns of Medicaid Cuts Killing People in Sarcastic Apology Video
Iowa Sen. Joni Ernst is facing backlash after posting a sarcastic video from a cemetery in response to criticism over her dismissive remarks about Medicaid cuts potentially leading to deaths. On May 30, during a town hall in Parkersburg, Iowa, Ernst was confronted by a concerned constituent about proposed Medicaid cuts in Republicans' spending bill. The legislation is projected to slash federal Medicaid funding by $723 billion over ten years and leave 7.6 million more Americans uninsured, according to the Congressional Budget Office. When the audience member shouted "people will die," Ernst responded with, "We all are going to die," leading to immediate outrage from critics and Democrats. In the days following the town hall, Ernst doubled down with a sarcastic Instagram story filmed in a cemetery. Last month France confirmed it would withdraw its contingent of hundreds of troops stationed in Burkina Faso AFP "I made an incorrect assumption that everyone understood that yes, we are all going to perish from this Earth," she said. She then mocked critics by referencing the tooth fairy and invoking Christianity, adding, "For those that would like to see eternal and everlasting life, I encourage you to embrace my lord and savior, Jesus Christ." Ernst later blamed the backlash on "hysteria... from the left," while defending the tax bill as focused on protecting only eligible Medicaid recipients, the Des Moines Register reported. The video sparked additional criticism from health care advocates and Democrats who said Ernst's tone trivialized the real human cost of Medicaid cuts. Protesters have organized outside her Iowa offices, while several advocacy organizations have launched digital campaigns urging constituents to pressure lawmakers to oppose the bill. The Senate is expected to vote on the spending bill later this summer. Originally published on Latin Times
